Listed

abrdn Life Sciences Investors

HQLNYSECIK 884121OtherFiscal year ends Sep 30

Financial statements for this company are not loaded yet.

Financial statements

Not loaded yet. We load companies from EDGAR in turn; this page fills in when this company’s filings and XBRL facts are ingested.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding abrdn Life Sciences Investors
FundQuarter endedReported valueSharesPut or callChange on the quarter before
MORGAN STANLEY2026-06-30$35.5m1,771,848Added+200,834
RAYMOND JAMES FINANCIAL INC2026-06-30$13.8m689,134Added+27,822
LPL Financial LLC2026-06-30$10.3m514,161Added+35,359
Allspring Global Investments Holdings, LLC2026-06-30$9.1m455,124Added+92,589
NEEDHAM INVESTMENT MANAGEMENT LLC2026-06-30$8.9m443,041Added+13,468
FLAGSHIP HARBOR ADVISORS, LLC2026-06-30$8.0m400,765Added+18,048
AMERIPRISE FINANCIAL INC2026-06-30$3.9m195,451Added+3,690
Advisors Asset Management, Inc.2026-06-30$3.4m169,812Added+9,394
180 WEALTH ADVISORS, LLC2026-06-30$3.1m152,829Added+3,271
RIVERNORTH CAPITAL MANAGEMENT, LLC2026-06-30$3.0m150,000Reduced−48,730

Recent filings

All 349 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

abrdn Life Sciences Investors, recent filings
FiledFormWhat it isAccession number
2026-02-2322:50 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-26-001121
2026-02-1123:53 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-26-000816
2026-01-0821:42 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-26-000129
2025-11-2416:36 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-25-016997
2025-09-2617:17 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-25-015817
2025-09-0320:58 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-25-015278
2025-04-0101:49 ETSCHEDULE 13D/AOwnership report, active investor, amended0001062993-25-006767
2024-06-0313:15 ETSC 13D/AOwnership report, active investor, amended0001062993-24-011603
2024-04-2914:52 ETSC 13D/AOwnership report, active investor, amended0001062993-24-008941
2024-04-2220:12 ETDEF 14AProxy statementPeriod 2024-06-250001104659-24-049993

Latest annual report

No annual report is in coverage for this company.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
884121
Tickers
HQL
Exchange
NYSE
SIC code
not reported
Sector
Other
Fiscal year ends
Sep 30
Incorporated in
MA
Filer category
not reported
Former names
TEKLA LIFE SCIENCES INVESTORS (to 2023-10-05); H&Q LIFE SCIENCES INVESTORS (to 2014-09-18)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.